Range Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.51M Buy
5,427
+161
+3% +$165K 1.78% 9
2026
Q1
$4.84M Buy
5,266
+142
+3% +$144K 1.63% 8
2025
Q4
$5.51M Buy
5,124
+329
+7% +$315K 1.91% 5
2025
Q3
$3.66M Sell
4,795
-206
-4% -$153K 1.32% 16
2025
Q2
$3.9M Buy
5,001
+168
+3% +$131K 1.53% 9
2025
Q1
$3.99M Buy
4,833
+304
+7% +$253K 1.77% 5
2024
Q4
$3.5M Buy
4,529
+3,744
+477% +$3.1M 1.61% 8
2024
Q3
$695K Sell
785
-3,440
-81% -$3.09M 0.96% 22
2024
Q2
$3.82M Buy
4,225
+60
+1% +$48K 1.95% 4
2024
Q1
$3.24M Buy
4,165
+60
+1% +$42.7K 1.68% 5
2023
Q4
$2.39M Buy
4,105
+28
+0.7% +$16.3K 1.44% 9
2023
Q3
$2.19M Buy
4,077
+1,613
+65% +$831K 1.45% 9
2023
Q2
$1.16M Sell
2,464
-220
-8% -$92.3K 0.73% 50
2023
Q1
$922K Sell
2,684
-213
-7% -$71.8K 0.6% 64
2022
Q4
$1.06M Buy
2,897
+17
+0.6% +$6.03K 0.72% 50
2022
Q3
$931K Sell
2,880
-975
-25% -$309K 0.72% 55
2022
Q2
$1.25M Sell
3,855
-805
-17% -$242K 0.91% 40
2022
Q1
$1.33M Sell
4,660
-51
-1% -$13.1K 0.85% 40
2021
Q4
$1.3M Sell
4,711
-116
-2% -$29.4K 0.86% 40
2021
Q3
$1.11M Sell
4,827
-147
-3% -$36.3K 0.8% 47
2021
Q2
$1.14M Buy
4,974
+784
+19% +$157K 0.84% 43
2021
Q1
$783K Buy
+4,190
New +$820K 0.71% 58

Other funds holding LLY

Range Financial Group's LLY Position: Q2 2026 in Review

Range Financial Group increased its Eli Lilly (LLY) stake by 3.1% in Q2 2026, buying an estimated $165K and bringing the position to 5,427 shares worth $6.51M. The position accounts for 1.78% of the portfolio, ranked #9.

Range Financial Group first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Range Financial Group held 5,427 shares of Eli Lilly worth $6.51M as of Q2 2026.
  • Range Financial Group bought 161 Eli Lilly shares in Q2 2026, an estimated $165K.
  • Eli Lilly made up 1.78% of Range Financial Group's portfolio in Q2 2026, its #9 holding.
  • Range Financial Group first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Range Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.